Citrus × aurantium (Bergamot Orange)

Bergamot orange (Citrus × aurantium var. bergamia) contains bergamot essential oil with neuroprotective compounds that may protect neural cells from NMDA-induced damage at 0.01% concentrations. The fruit provides vitamin C (45-90mg per 100g) and citrus bioflavonoids including hesperidin and naringin.

Origin & History

Citrus × aurantium (bergamot orange) is a hybrid citrus fruit originating from Calabria, Italy, primarily cultivated for its peel from which essential oil and extracts are obtained through cold-pressing. The essential oil yields a volatile fraction (93-96%) rich in monoterpenes like limonene (25-53%) and linalyl acetate (15-40%), while powder forms are produced through water extraction and spray-drying.

Historical & Cultural Context

The research dossier contains no documentation of traditional medicinal uses for bergamot orange. Modern applications are limited to perfumery, cosmetics, food flavoring, and confections via essential oil extraction.

Health Benefits

• Potential neuroprotective effects - preliminary in vitro research shows 0.01% bergamot essential oil may protect against NMDA-induced neural damage
• Contains vitamin C - powder forms provide 45-90mg ascorbic acid per 100g
• Rich in citrus bioflavonoids including hesperidin, naringin, and neoeriocitrin - though specific health effects lack clinical validation
• Source of antioxidant compounds through various polyphenols - no human trials available
• May support general wellness through its 568 active phytochemicals - evidence limited to compositional analysis only

How It Works

Bergamot essential oil components appear to modulate NMDA receptor-mediated excitotoxicity, protecting neural cells from calcium influx and oxidative damage. Citrus bioflavonoids like hesperidin and naringin act as antioxidants by scavenging free radicals and chelating metal ions. The vitamin C content supports collagen synthesis and serves as a cofactor for neurotransmitter production.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses were identified in the available research for bergamot orange. The only experimental evidence comes from in vitro neuroprotection studies showing bergamot essential oil at 0.01% concentration counteracted NMDA-induced cellular damage, but this lacks human validation.

Clinical Summary

Current evidence is limited to preliminary in vitro studies showing bergamot essential oil at 0.01% concentration may protect against NMDA-induced neural damage in cell culture models. No human clinical trials specifically examining bergamot orange's neuroprotective effects have been published. The vitamin C and bioflavonoid content are well-established through analytical studies of the fruit composition. More rigorous clinical research is needed to validate potential therapeutic applications.

Nutritional Profile

Bergamot orange (Citrus × aurantium, Bergamot group) has a nutritional profile broadly similar to other bitter/sour citrus but with a distinctive polyphenolic fingerprint. Per 100g of fresh juice (approximate): Energy 30–40 kcal; Carbohydrates 7–9g (primarily fructose, glucose, sucrose); Protein 0.5–0.7g; Fat <0.2g; Dietary fiber 0.2–0.4g in juice (whole fruit pulp/albedo significantly higher at 2–4g/100g due to pectin). Vitamin C (ascorbic acid): 30–50mg/100g in fresh juice, 45–90mg/100g in dried powder forms; Potassium 140–180mg/100g; Calcium 20–35mg/100g; Magnesium 8–12mg/100g; Phosphorus 10–18mg/100g; trace iron 0.2–0.4mg/100g. BIOACTIVE POLYPHENOLS (distinguishing feature): Exceptionally rich in flavanone glycosides — neoeriocitrin (50–200mg/L juice), naringin (30–150mg/L), neohesperidin (80–250mg/L). Also contains flavone glycosides such as rhoifolin, neodiosmin, and chrysoeriol derivatives. Notably high in the unique statin-like 3-hydroxy-3-methylglutaryl (HMG) flavanone conjugates: brutieridin (~15–50mg/L) and melitidin (~10–40mg/L), which are structurally analogous to HMG-CoA reductase substrates and are proposed to underlie bergamot's lipid-modulating activity in supplemental extracts. Furocoumarins (bergapten, bergamottin) present especially in peel and essential oil at 100–3000 ppm depending on extraction — these are photoactive and can inhibit CYP3A4, affecting drug bioavailability. Essential oil (from flavedo) is dominated by limonene (25–50%), linalool (5–15%), and linalyl acetate (20–40%), with minor amounts of β-pinene, γ-terpinene, and bergaptol. Carotenoid content is modest (β-carotene <0.1mg/100g). Organic acids: citric acid 4–6g/100g juice (dominant acid), malic acid 0.1–0.3g/100g. BIOAVAILABILITY NOTES: Flavanone glycosides (naringin, neoeriocitrin, neohesperidin) have relatively low oral bioavailability (5–15%) as they require colonic microflora hydrolysis to release aglycones (naringenin, eriodictyol, hesperetin); Tmax is typically 4–7 hours. Bergamottin and furanocoumarins are well-absorbed and can irreversibly inhibit intestinal CYP3A4, potentially increasing bioavailability of co-administered pharmaceuticals (similar to grapefruit interaction). Vitamin C bioavailability from bergamot is comparable to other citrus sources (~70–90% absorption). HMG-flavanones (brutieridin, melitidin) pharmacokinetics remain poorly characterized in humans; their lipid-lowering effects are primarily demonstrated with concentrated polyphenolic extracts (typically standardized to 25–40% total flavonoids, dosed at 500–1500mg/day in clinical studies).

Preparation & Dosage

No clinically studied dosage ranges have been established for bergamot orange extracts, essential oils, or powders due to absence of human trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other citrus bioflavonoids, vitamin C, hesperidin, naringin, limonene-containing supplements

Safety & Interactions

Bergamot essential oil contains bergapten and other furocoumarins that can cause photosensitivity reactions when applied topically before sun exposure. Oral consumption of bergamot fruit is generally recognized as safe, though essential oil concentrates may interact with medications metabolized by CYP3A4 enzymes. Individuals with citrus allergies should avoid bergamot products. Pregnancy and breastfeeding safety data for concentrated bergamot supplements is insufficient.